NZX-listed Cannasouth has reported an unaudited full-year loss of $3.5 million as it invests to try establish itself in the New Zealand medical cannabis market.
The $3.5m loss for the year to December 31 is up 59% on the 2019 loss of $2.2m. Revenue of $131,140, was up 146% due to a full year of
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
